PRESKORN: Kansas University School of Medicine-Wichita, Wichita, KS
This column has been adapted with permission from Appendix I in Preskorn SH. Drug-drug Interactions With an Emphasis on Psychiatric Medications, 1st ed. West Islip, NY and Durant, OK: Professional Communications; 2018. To order a copy of the book, readers can call 1-800-337-9838 or visit the Professional Communications website at: www.pcibooks.com.
S.H.P. has worked with over 135 pharmaceutical companies in the United States and throughout the world. Over the past year, he has received grants/research support from or has served as a consultant, on the advisory board, or on the speaker’s bureau for Alkermes, Allergan, Bionomics, BioXcel, Cercor, Food and Drug Administration, Janssen, National Institute of Mental Health, Merck, Novaritis, Pfizer, Rugen Holdings, and Sunovion.
Please send correspondence to: Sheldon H. Preskorn, MD, University of Kansas Medical Center, 1010 N. Kansas, Wichita, KS 67217.